-
Yan Noi's new antibiotic cefiderocol treatment hospital obtained pneumonia adult patients 3 study reached the main endpoint
Time of Update: 2020-06-08
recently, Japan's Shionogi company (http:// announced that it had developed a new antibiotic, cefiderocol, to reach the main endpoint of the experimental (http:// in the phase 3 study of APEKS
-
FDA approves Epson Bio to expand Dysport injection spree
Time of Update: 2020-06-08
recently, the , epson bio pharmaceutical (http:// company (http:// announced that the U.S Food and Drug (http:// Administration ( FDA (http:// ) has approved the expansion of the scope of D
-
FDA grants bempegal desleukin and Opdivo immunocombination therapy breakthrough drug qualification
Time of Update: 2020-06-08
recently announced jointly with BMS that the U.S Food and Drug (http:// Administration ( FDA (http:// has awarded bempegaldedesleukin (BEMMTR-214) and Opdivo (nivolumab, Navudan) immunocomas b
-
U.S. Chrysalis lead compound TP508 is qualified by FDA and EJEC orphan drug
Time of Update: 2020-06-08
Recently, according to foreign media reports, the U.S bio pharmaceutical (http:// company (http:// Chrysalis BioTherapeutics announced that its lead compound TP508 was fda (http:// and the E
-
Green leaf pharmaceutical ansofasin reprieve tablet (LY03005) has been submitted for clinical trials in Japan
Time of Update: 2020-06-08
Recently, the http:// Group of Green leaf Pharmaceutical s announced that its new compound for the treatment of depression, the Antufaxin Reprieve (LY03005), has submitted a clinical trial (http
-
Alkahest achieves positive results in clinical trials of the treatment of Alzheimer's disease in Phase 2 of the research therapy GRF6019
Time of Update: 2020-06-08
recently, Alkahest (http:// announced positive results in its treatment of GRF6019, a phase 2 clinical trial (http:// in patients with mild to moderate Alzheimer's disease (AD) GRF6019 consis
-
FDA grants Moderna's mRNA-1893 fast-track eligibility for Zika virus vaccine
Time of Update: 2020-06-08
The U.S Food and Drug (http:// Administration http:// (http:// has granted its a fast-track qualification for the Zika virus vaccine mRNA-1893, the http:// company announced Now, Moderna
-
Phase 3 clinical trial of Diroximel fumarate for treatment of RRMS yields positive top-line results
Time of Update: 2020-06-08
recently, the (http:// of the company of Alkermes and Biogen announced positive top-line results a Phase 3 clinical trial (http:// for the treatment of recurrent recurrent multiple sclerosis (R
-
GlaxoSmithKline submits new drug application for daprodustat for renal anemia to Japan's Ministry of Health, Labour and Welfare
Time of Update: 2020-06-08
recently, GlaxoSmithKline (GSK) submitted to the Ministry of Health, Labour and Welfare (MHLW) a application for a new drug (http:// (NDA) to approve oral hypoxic-inducing factor protalysinase in
-
Novartis Ligelizumab (QGE031) treats Patients with CSU with higher remission rates
Time of Update: 2020-06-08
CSU is a severe skin disease with unpredictable seizures, symptoms including spontaneous swelling and itching of the skin Novartis (http:// announced that the company's development of anti-IgE h
-
Gilead submitted a new drug application for JAK1 inhibitor filgotinib to MHLW
Time of Update: 2020-06-08
recently, Gilead Sciences announced that the company (http:// has submitted to The Ministry of Health, Labour and Welfare (MHLW) an application for new drug (http:// (NDA) of the oral selectiv
-
U.S. Antimicrobial Advisory Board backs Gilead Descovy to reduce risk of HIV infection
Time of Update: 2020-06-08
AIDS is an infectious disease caused by HIV infection The development of modern antiviral drug (http:// and the rise of "cocktail therapy" has allowed HIV-infected people to control their conditi
-
FDA grants Achillion's danicopan breakthrough therapy
Time of Update: 2020-06-08
a sleeping hemoglobinuria (PNH) is a acquired, life-threatening rare blood disease characterized by the destruction of red blood cells (hemolytic anemia), blood clots (thrombosis), impaired bone mar
-
FDA accepts new drug application for Sumitomo Pharmaceuticals dasotraline to treat BED
Time of Update: 2020-06-08
recently, Sumitomo Pharmaceutical (http:// u.S sub- company (http:// Sunovion Pharma announced that the U.S Food and Medicines (http:// Administration ( FDA (http:// ) has accepted the tre
-
Cyramza and Tarceva combination therapy first-line treatment NSCLC critical Phase 3 trial yielded positive results
Time of Update: 2020-06-08
recently, Lilly announced that its anti-vascularly generated mono-anti- drug (http:// Cyramza (ramucirumab) and Roche's tyrosine kinase inhibitor Tarceva (erlotinib, erlotinib) combined the rapto
-
Exampon injection drug Dysport approved by FDA for treatment of limb spasms in children aged two and over
Time of Update: 2020-06-08
Today, Ipsen company (http:// announced that its injectable drug (http:// Dysport has been approved by the FDA (http:// for the treatment of limb spasms in children aged two and over About
-
CHMP recommends approval of 2 drug offers for Perivane's Squibb Opdivo
Time of Update: 2020-06-08
Recently, BMS announced that the European Medicines (http:// Administration (EMA) human products for medicine (http:// products (http:// Committee (CHMP) recommended the approval of Opdivo (
-
Pro Pharma's new drug, antatory hydrochloride, gets FDA approval
Time of Update: 2020-06-08
recently, Plo Pharmaceuticals announced that its wholly-owned sub- company (http:// Zhejiang Jutai Pharmaceutical Co., Ltd to the United States FDA to declare the new drug http:// (http://
-
Gilead and Galapagos announce that the listing of applications for filgotinib treatment of ADULT patients with RA will be accepted by EMA
Time of Update: 2020-06-08
The European drug (http:// Authority (EMA) has accepted applications for listing of adult patients with oral selective JAK1 inhibitor filgotinib for treating rheumatoid arthritis (RA), the u.S P
-
CHMP recommends approval of Trogarzo (ibalizumab) for multidrug-resistant HIV-1 treatment
Time of Update: 2020-06-08
The seint, a partner of Taiwan's Zhongyu new drug (http:// , canada's Pharmaceutical (http:// company (http:// the european medicines Authority (http:// administration (http:// product
